- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| TREACE MEDICAL CONCEPTS Aktie jetzt für 0€ handeln | |||||
| 18.06. | Treace Medical Concepts, Inc.: Treace Announces First Surgical Case with the HyperPlate XM Dynamic Compression Locking Implant System | 2 | GlobeNewswire (USA) | ||
| 20.05. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.05. | TREACE MEDICAL CONCEPTS, INC. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 08.05. | Treace Medical: Aktie steigt nach übertroffenen Quartalszahlen trotz Umsatzminus | 1 | Investing.com Deutsch | ||
| 08.05. | Treace Medical Concepts GAAP EPS of -$0.28 beats by $0.03, revenue of $47.2M beats by $1.15M | 3 | Seeking Alpha | ||
| 08.05. | Treace Medical Concepts, Inc.: Treace Medical Concepts Reports First Quarter 2026 Financial Results | 783 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| 08.05. | TREACE MEDICAL CONCEPTS, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 08.05. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 24.04. | Treace Medical Concepts, Inc.: Treace to Report First Quarter 2026 Financial Results on May 8, 2026 | 2 | GlobeNewswire (USA) | ||
| 09.04. | Stifel belässt Treace Medical auf 'Halten' mit Kursziel von 3 US-Dollar | 3 | Investing.com Deutsch | ||
| 09.04. | Stifel maintains Hold on Treace Medical stock, $3 target unchanged | 1 | Investing.com | ||
| 09.04. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 07.04. | Treace Medical Concepts, Inc.: Treace Announces First Surgical Cases with the SuperBite Compression Screw System | 293 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| 27.02. | Treace Medical signals 2026 revenue target of $200M-$212M while expanding comprehensive bunion solutions | 4 | Seeking Alpha | ||
| 27.02. | Treace Medical Concepts GAAP EPS of -$0.15 in-line, revenue of $62.5M beats by $0.63M | 2 | Seeking Alpha | ||
| 27.02. | Treace Medical Concepts: EPS verfehlt Schätzungen - Umsatz besser als erwartet | 2 | Investing.com Deutsch | ||
| 27.02. | Treace Medical Concepts Q4 Earnings Summary & Key Takeaways | 1 | Benzinga.com | ||
| 27.02. | TREACE MEDICAL CONCEPTS, INC. - 10-K, Annual Report | - | SEC Filings | ||
| 27.02. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.02. | Treace Medical Concepts, Inc.: Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results | 776 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,070 | -0,29 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| TANDEM DIABETES | 13,700 | +0,74 % | Tandem Diabetes Care, Inc.: Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets | Compatibility now available in five countries, with additional markets expected throughout 2026.Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company... ► Artikel lesen | |
| VERU | 2,300 | -0,43 % | Top Biotech Gainers: VERU Teams Up With NVO, ABSI On Watch, ALVO Resubmits BLAs To FDA... | REYKJAVIK (dpa-AFX) - Thursday's top gainers include Veru, following a Novo Nordisk collaboration; Health Catalyst, following a divestment of its revenue workflow and analytics software business... ► Artikel lesen | |
| SENSEONICS | 4,500 | +1,81 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,969 | -1,18 % | Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors | BRISANE, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) ("Tempest" or "Tempest Therapeutics") today announced the appointment of two independent directors, Drake... ► Artikel lesen | |
| VIRIDIAN THERAPEUTICS | 16,800 | 0,00 % | Aktien New York Ausblick: Nasdaq erholt - Comcast-Aufspaltung beflügelt Branche | NEW YORK (dpa-AFX) - Die Anleger dürften den jüngsten Kursrückschlag an der New Yorker Tech-Börse Nasdaq direkt zum Wiedereinstieg nutzen. Im Fokus stehen am Montag die jüngste Entspannung im davor... ► Artikel lesen | |
| SINTX TECHNOLOGIES | 1,570 | +0,64 % | SINTX Technologies, Inc.: SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders | SALT LAKE CITY, Utah, June 22, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), a leader in advanced silicon nitride ceramics and advanced material technologies... ► Artikel lesen | |
| VYOME | 2,180 | 0,00 % | Mitschrift des Earnings Call: Vyome Holdings weist für Q1 2026 eine starke Cash-Position aus | ||
| VIVANI MEDICAL | 1,210 | -0,82 % | Vivani Medical, Inc.: Vivani Medical schließt Vereinbarung mit Novo Nordisk zur Evaluierung von NPM-139, einem miniaturisierten, ultra-langwirkenden Semaglutid-Implantat zur langfristigen Gewichtsregulierung | Novo Nordisk wird eine nicht-exklusive interne Evaluierung der von Vivani hergestellten Semaglutid-Implantate durchführenALAMEDA, Kalifornien, July 08, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc.... ► Artikel lesen | |
| STEREOTAXIS | 1,386 | -0,14 % | Stereotaxis, Inc.: Stereotaxis Completes Acquisition of Robocath | ST. LOUIS and ROUEN, France, July 09, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced... ► Artikel lesen | |
| VIEMED HEALTHCARE | 10,400 | -0,95 % | Reportable, Inc.: Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 1Q26 | Dallas, Texas--(Newsfile Corp. - May 12, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (NASDAQ: VMD). Viemed's 1Q26 results... ► Artikel lesen | |
| VIVOS THERAPEUTICS | 0,408 | -0,34 % | Vivos Therapeutics, Inc: Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity | LITTLETON, Colo., June 22, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment... ► Artikel lesen | |
| TENON MEDICAL | 0,205 | 0,00 % | Tenon Medical, Inc. - 8-K, Current Report | ||
| SEASTAR MEDICAL | 4,810 | +0,21 % | SeaStar Medical sponsors pediatric kidney injury summit |
Das Unternehmen TREACE MEDICAL CONCEPTS INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +0,23 % bei einem Aktienkurs von 4,450 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TREACE MEDICAL CONCEPTS INC finden Sie auf Wallstreet Online.